The Role of Diagnostic Tools in the Management of Ventilator Associated Lower Respiratory Tract Infections

Ventilator-associated pneumonia (VAP) remains a leading healthcare-associated infection in intensive care units and is closely associated with prolonged mechanical ventilation, excessive antimicrobial exposure, higher costs, and poor clinical outcomes. Despite decades of clinical trials and guideline development, bedside diagnosis remains limited by the absence of a biological reference standard. Conventional criteria combine nonspecific clinical, radiographic, and microbiological findings and cannot reliably distinguish parenchymal infection from airway colonization, endotracheal tube biofilm, or sterile pulmonary inflammation. Syndromic multiplex polymerase chain reaction panels, metagenomic next-generation sequencing, and host response profiling have greatly increased analytical sensitivity and shortened the time to microbiological information. They have also exposed the amount of microbial and inflammatory noise present in the ventilated airway. Detection of an organism, a resistance determinant, or systemic inflammation does not by itself establish causality. This review examines the strengths and limitations of clinical scores, imaging, respiratory sampling, conventional culture, rapid molecular assays, antimicrobial resistance testing, systemic and alveolar biomarkers, host transcriptomics, breath analysis, and artificial intelligence-based models. It proposes that VAP should be approached as a time-updated probability of tissue invasive infection rather than a binary diagnosis. A practical host-pathogen attribution framework should integrate the timing and trajectory of respiratory deterioration, specimen quality, relative pathogen burden and dominance, resistance and virulence signals, local and systemic host responses, prior antimicrobial exposure, and competing diagnoses. Diagnostic tests should be ordered only when a predefined management decision is linked to the result, followed by structured reassessment at 48 to 72 hours. This approach may improve antimicrobial targeting while reducing treatment of colonization and other noninfectious mimics.

Authors

Institutions

Publication Details

Journal
Seminars in Respiratory and Critical Care Medicine
Published
2026-11-20
DOI
https://doi.org/10.1055/a-3002-3157
Primary Topic
Nosocomial Infections in ICU
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Role of Diagnostic Tools in the Management of Ventilator Associated Lower Respiratory Tract Infections

Ignacio Martín‐Loeches, Yunsong Yu
Seminars in Respiratory and Critical Care Medicine
Nosocomial Infections in ICU
article

The Role of Diagnostic Tools in the Management of Ventilator Associated Lower Respiratory Tract Infections

Ignacio Martín‐Loeches, Yunsong Yu
article en

Abstract

Ventilator-associated pneumonia (VAP) remains a leading healthcare-associated infection in intensive care units and is closely associated with prolonged mechanical ventilation, excessive antimicrobial exposure, higher costs, and poor clinical outcomes. Despite decades of clinical trials and guideline development, bedside diagnosis remains limited by the absence of a biological reference standard. Conventional criteria combine nonspecific clinical, radiographic, and microbiological findings and cannot reliably distinguish parenchymal infection from airway colonization, endotracheal tube biofilm, or sterile pulmonary inflammation. Syndromic multiplex polymerase chain reaction panels, metagenomic next-generation sequencing, and host response profiling have greatly increased analytical sensitivity and shortened the time to microbiological information. They have also exposed the amount of microbial and inflammatory noise present in the ventilated airway. Detection of an organism, a resistance determinant, or systemic inflammation does not by itself establish causality. This review examines the strengths and limitations of clinical scores, imaging, respiratory sampling, conventional culture, rapid molecular assays, antimicrobial resistance testing, systemic and alveolar biomarkers, host transcriptomics, breath analysis, and artificial intelligence-based models. It proposes that VAP should be approached as a time-updated probability of tissue invasive infection rather than a binary diagnosis. A practical host-pathogen attribution framework should integrate the timing and trajectory of respiratory deterioration, specimen quality, relative pathogen burden and dominance, resistance and virulence signals, local and systemic host responses, prior antimicrobial exposure, and competing diagnoses. Diagnostic tests should be ordered only when a predefined management decision is linked to the result, followed by structured reassessment at 48 to 72 hours. This approach may improve antimicrobial targeting while reducing treatment of colonization and other noninfectious mimics.

Seminars in Respiratory and Critical Care Medicine
Trinity College Dublin (IE), Sir Run Run Shaw Hospital (CN), Zhejiang Provincial People's Hospital (CN), St. James's Hospital (IE), Hangzhou Medical College (CN), Zhejiang University (CN)
Good health and well-being
Nosocomial Infections in ICU
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon